Semaglutide is a GLP-1 medication that helps patients lose 1015% of total body weight
The risk of pancreatitis can be minimized by addressing and mitigating risk factors from previous episodes, regulating the rate of weight loss by adjusting the GLP-1 receptor agonist dose and the content and frequency of meals, closely monitoring patients during GLP-1 receptor agonist therapy, and implementing appropriate precautionary measures
Some common gastrointestinal GLP-1 side effects include: [8] GI side effects are most common when starting or upping your dose, but they usually ease as your body adjusts
The MHRA will continue to closely monitor the safety and effectiveness of semaglutide in clinical use and encouraged patients to report suspected side effects through the Yellow Card scheme
But typical protocols from the science literature suggest: Standard Protocol : 12 sprays per nostril, 12 times daily Cycle Length : 46 week cycles with 24 week breaks Best Timing : Morning and evening for steady plasma levels Tips to Optimize Absorption of Your BPC Spray Want the best results from your BPC 157 peptide nasal spray
Insurance Coverage Reality (2026) Per KFF's 2025 Employer Health Benefits Survey: About 40% of US employer plans cover GLP-1s for obesity